Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The White House announced yesterday that Novo and Lilly have agreed to sell their GLP-1 obesity drugs at substantially lower prices to Medicare and Medicaid, and to lower their direct-to-consumer prices
Multiple, randomized controlled trials have been initiated to determine whether GLP-1 medicines have therapeutic impact on these disorders
1 1 1 1
Current recommendations suggest delaying colonoscopy until age 30 in these carriers, thus study authors suggest that this might lead to missed opportunities for Permanent link to this article: ICARE Newsletter Spring 2025 Lynch Syndrome: Personalizing Risks ICARE Newsletter Spring 2025 Lynch Syndrome: Personalizing Risks MyLynch is a resource for Lynch syndrome patients that provides personal cancer risks, education on interventions, and adjusted risk estimates, depending on the intervention(s) the patient chooses to pursue
US$ 21.41
US$ 23.31
US$ 21.47
US$ 22.98
US$ 22.28
